Aims and Scope of Expert Opinion on Drug Safety
Expert Opinion on Drug Safety is a monthly peer-reviewed medical journal publishing review articles on all aspects of pharmacovigilance and original papers on the clinical implications of drug treatment safety issues. It was established in 2002 and is published by Informa. The editor-in-chief is Roger McIntyre (University of Toronto). Less
Key Metrics
CiteScore 

6.1
Eigenfactor 

0.005 - 0.01
H-Index 

81
Impact Factor 

< 5
SJR 

Q2Pharmacology (medical)

SNIP 

1.17
Recommended pre-submission checks
Powered by 

Topics Covered on Expert Opinion on Drug Safety
Expert Opinion on Drug Safety Journal Specifications
| Overview | |
| Publisher | TAYLOR & FRANCIS LTD |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 2002 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Expert Opinion on Drug Safety ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Expert Opinion on Drug Safety
Long-term efficacy and safety of intra-articular corticosteroid injections in patients with knee osteoarthritis
- 22 Jul 2026
- Expert Opinion on Drug Safety
Safety of Janus kinase inhibitors in patients with moderate-to-severe atopic dermatitis: a systematic review and meta-analysis of observational studies
- 18 Jul 2026
- Expert Opinion on Drug Safety
Safety profile of dual TIGIT and PD-L1 blockade with tiragolumab plus atezolizumab in solid tumors: a systematic review and meta-analysis of randomized controlled trials
- 16 Jul 2026
- Expert Opinion on Drug Safety
Safety and efficacy of DOACs in clinically complex phenotypes of patients with atrial fibrillation: focus on frailty, multimorbidity and polypharmacy
- 16 Jul 2026
- Expert Opinion on Drug Safety
Trigger tool methodologies in hospital settings: reappraising their role in pharmacovigilance and digital safety surveillance
- 12 Jul 2026
- Expert Opinion on Drug Safety
Could anticholinergics accelerate ALS progression? A critical perspective on drug safety and disease vulnerability.
- 30 Jun 2026
- Expert opinion on drug safety
Long-term efficacy and safety of intra-articular corticosteroid injections in patients with knee osteoarthritis
- 22 Jul 2026
- Expert Opinion on Drug Safety
Safety of Janus kinase inhibitors in patients with moderate-to-severe atopic dermatitis: a systematic review and meta-analysis of observational studies
- 18 Jul 2026
- Expert Opinion on Drug Safety
Safety profile of dual TIGIT and PD-L1 blockade with tiragolumab plus atezolizumab in solid tumors: a systematic review and meta-analysis of randomized controlled trials
- 16 Jul 2026
- Expert Opinion on Drug Safety
Safety and efficacy of DOACs in clinically complex phenotypes of patients with atrial fibrillation: focus on frailty, multimorbidity and polypharmacy
- 16 Jul 2026
- Expert Opinion on Drug Safety
Trigger tool methodologies in hospital settings: reappraising their role in pharmacovigilance and digital safety surveillance
- 12 Jul 2026
- Expert Opinion on Drug Safety
Could anticholinergics accelerate ALS progression? A critical perspective on drug safety and disease vulnerability.
- 30 Jun 2026
- Expert opinion on drug safety